Current issue
Archive
Online first
About the Journal
Editorial Office
Editorial Board
Publisher
Editorial Policies
Ethical standards and procedures
Abstracting and indexing
Reviewers
Honorary Reviewers
Subscription
Contact
Most read articles
Instructions for authors
Article processing charge (APC)
Books and Events
Books
Events
REVIEW PAPER
Nail psoriasis – what a rheumatologist should know about
Submission date: 2016-12-27
Acceptance date: 2017-02-14
Online publication date: 2017-03-22
Publication date: 2017-02-28
Reumatologia 2017;55(1):52-55
KEYWORDS
TOPICS
ABSTRACT
Psoriasis is a chronic recurrent inflammatory skin disease with prevalence of 1–3%. Nail psoriasis affects 10–90% of patients with plaque psoriasis.
The aim of the article is to review the literature for the correlation between nail psoriasis and psoriatic arthritis (PsA) to provide rheumatologists a short review on features of nail psoriasis, methods of their assessment and possible clinical repercussions.
The PubMed database was searched using the key words ‘nail psoriasis’ and ‘psoriatic arthritis’.
Psoriasis involving the nail matrix shows up as changes such as pitting, Beau lines, leukonychia, red spots in the lunula, or nail plate crumbling. Nail bed psoriasis manifests as onycholysis, oil drops (or salmon patches), dyschromia, splinter hemorrhages, or subungual hyperkeratosis. Nail psoriasis and psoriatic lesions in the gluteal cleft and on the scalp usually accompany PsA, especially in adult men.
The aim of the article is to review the literature for the correlation between nail psoriasis and psoriatic arthritis (PsA) to provide rheumatologists a short review on features of nail psoriasis, methods of their assessment and possible clinical repercussions.
The PubMed database was searched using the key words ‘nail psoriasis’ and ‘psoriatic arthritis’.
Psoriasis involving the nail matrix shows up as changes such as pitting, Beau lines, leukonychia, red spots in the lunula, or nail plate crumbling. Nail bed psoriasis manifests as onycholysis, oil drops (or salmon patches), dyschromia, splinter hemorrhages, or subungual hyperkeratosis. Nail psoriasis and psoriatic lesions in the gluteal cleft and on the scalp usually accompany PsA, especially in adult men.
REFERENCES (25)
1.
Schons KR, Knob CF, Murussi N, et al. Nail psoriasis: a review of the literature. An Bras Dermatol 2014; 89: 312-317.
2.
Elkayam O, Ophir J, Yaron M, et al. Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution. Clin Rheumatol 2000; 19: 301-305.
3.
Williamson L, Dalbeth N, Dockerty JL, et al. Extended report: nail disease in psoriatic arthritis – clinically important, potentially treatable and often overlooked. Rheumatology 2004; 43: 790-794.
4.
Pourchot D, Bodemer C, Phan A, et al. Evaluation in 313 Children with Psoriasis. Pediatr Dermatol 2016 22. doi: 10.1111/pde.13028.
5.
Sánchez-Regańa M, Umbert P. Diagnosis and management of nail psoriasis. Actas Dermosifiliogr 2008; 99: 34-43.
6.
Garbers LE, Slongo H, Fabricio LH, et al. Incidence, clinical manifestations and clipping of nail psoriasis in the dermatology center of the Hospital Universitário Evangélico de Curitiba. An Bras Dermatol 2016; 91: 300-305.
7.
Balestri R, Rech G, Rossi E, et al. Natural history of isolated nail psoriasis and its role as a risk factor for the development of psoriatic arthritis: a single center cross sectional study. Br J Dermatol 2016; doi: 10.1111/bjd.15026.
8.
Lawry M, Rich P. The nail apparatus: A guide for basic and clinical science. Curr Probl Dermatol 1999; 11: 163-208.
9.
Wiland P. Zmiany narządowe w chorobach reumatycznych. Górnicki Wydawnictwo Medyczne, Wrocław 2016.
10.
Rich P, Scher RK. Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003; 49: 206-212.
11.
Parrish CA, Sobera JO, Elewski BE. Modification of the Nail Psoriasis Severity Index. J Am Acad Dermatol 2005; 53: 745-746.
13.
Cassell SE, Bieber JD, Rich P, et al. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007; 34: 123-129.
14.
Castellanos-González M, Joven BE, Sánchez J, et al. Nail involvement can predict enthesopathy in patients with psoriasis. J Dtsch Dermatol Ges 2016; 14:1102-1107.
15.
Wong PCH, Leung YY, Li EK, et al. Measuring Disease Activity in Psoriatic Arthritis. Int J Rheumatol 2012; 2012: 839425.
16.
Acquitter M, Misery L, Saraux A, et al. Detection of subclinical ultrasound enthesopathy and nail disease in patients at risk of psoriatic arthritis. Joint Bone Spine 2016; pii: S1297-319X(16)30198-1.
17.
Gutierrez M, Kaeley GS, Bertolazzi C, et al. State of the art of ultrasound in the assessment of psoriasis and psoriatic arthritis. Expert Rev Clin Immunol 2016; doi: http://dx.doi.org/10.1080/1744....
18.
Paek SY, Thompson JM, Qureshi AA, et al. Comprehensive Assessment of the Psoriasis Patient (CAPP): A Report from the GRAPPA 2015 Annual Meeting. J Rheumatol 2016; 43: 961-964.
20.
Gladman DD, Mease PJ, Healy P, et al. Outcome measures in PsA. J Rheumatol 2007; 8: 1159-1166.
21.
Raychaudhuri SP, Wilken R, Sukhov AC, et al. Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies. J Autoimmun 2017; 76: 21-37.
22.
Lai TL, Pang HT, Cheuk YY, et al. Psoriatic nail involvement and its relationship with distal interphalangeal joint disease. Clin Rheumatol 2016; 35: 2031-2037.
23.
Errichetti E, Zabotti A, Stinco G, et al. Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis. J Dermatol 2016; 43: 1217-1220.
24.
Pasch MC. Nail psoriasis: a review of treatment options. Drugs 2016; 76: 675-705.
25.
Torii H, Nakano M, Yano T, et al. SPREAD Study Group Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study. J Dermatol 2016; doi: 10.1111/1346-8138.13698.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
